Key Takeaways
- A rebuilding year, not a breakout one: FY26 was about leadership, governance and capital readiness across all four businesses. The demerger scheme to separate Care Health from lending and broking is the headline structural move, but timelines and holding-company discount mitigation remain open questions.
- Care Health is the crown jewel and it is performing: Gross written premium crossed INR10,000 crores, retail health grew 37% YoY with market share gains, and combined ratio improved 120 bps. The GST exemption on individual health policies provided a material tailwind from October onward.
- Broking and NBFC are repaired, not yet scaled: Religare Broking posted a sharp Q4 rebound (PBT up 79% YoY) but full-year profit fell 26%. RFL is debt-free with 98% collection efficiency and a new CEO, but the multi-line NBFC product launch is still quarters away.
- Housing finance is the clear drag: The HFC lost INR18.6 crores for the full year on an AUM of just INR243 crores. Management asks for 12 to 18 months to turn it profitable, with scaling up requiring both opex and capex.
- What to watch next quarter: Whether the demerger scheme progresses toward regulatory filing, any concrete plan to address the holding-company discount, and the pace of NBFC product launches now that the RFL CEO has joined.
The Demerger & Holding Structure Puzzle
- Scheme approved by both boards: REL's lending, broking and ancillary financial services business will move to RFL, leaving REL as a pure-play health insurance holding company. REL shareholders will receive 1 RFL share for every REL share held upon implementation.
- The holding-company discount problem is acknowledged but unsolved: Investors have flagged that Care Health sitting inside a listed holding company will attract a discount. Management said it will keep the concern "at the back of our minds" and evaluate options at an appropriate stage, offering no specific mitigation plan.
- Reverse merger of Care is not ruled out but not committed: Asked whether a subsequent scheme could fold Care into REL, management said it will not amend the current demerger scheme but may evaluate a subsequent one, with no timeline given.
- Promoter stake increase toward the 26% IRDA threshold is also undated: Promoters currently hold around 30.3% in REL, but IRDA's requirement applies at the insurance entity level. Management said it will see what to do at an appropriate time.
Arjun Lamba: "We understand your concern, and we well acknowledge what the investors are saying... we will keep this at the back of our minds, and we will see what we have to do at an appropriate stage."
Care Health Insurance: The Earnings Engine
- Top line crossed INR10,000 crores with industry-beating retail growth: GWP reached INR11,417 crores versus INR9,200 crores the previous year. Retail health grew 37% YoY on a full premium basis, with market share reaching 11.6% of the overall industry and 19.7% within SAHI. On an 'n' basis, Care grew 9% faster than the industry.
- GST exemption unlocked demand from October: The removal of 18% GST on individual health insurance policies materially improved affordability. Retail growth accelerated to 40% in H2 FY26 versus 27% in H1, and management expects the momentum to sustain.
- Profitability improved on both an 'n' basis and Ind AS basis: PBT under Ind AS grew 55% excluding mark-to-market impact; on an 'n' basis it grew 38%. The Ind AS 117 impact was INR565 crores, and an INR64 crore mark-to-market loss on equity investments depressed reported PBT. Excluding that equity hit, PBT would have been INR583 crores.
- Combined ratio improved 120 bps to 101.4%: The improvement came from a 100 bps reduction in the loss ratio and a 20 bps improvement in the operating expense ratio. Underwriting loss narrowed by nearly INR50 crores to INR114 crores.
- The path to sub-100% combined ratio runs through operating leverage, not claims: Management expects the combined ratio to approach 100% within two years, driven entirely by better operating leverage as the renewal book scales, not by claims ratio improvement.
- Solvency and investment book are conservative: Solvency ratio stood at 1.68, or 1.70 excluding the mark-to-market equity hit. The investment book grew by over INR2,500 crores, with 93% in bonds and G-Secs and only 6% in AA-rated instruments. A planned INR600 crore capital infusion saw INR256 crores deployed in September 2025.
Ajay Shah: "This combined ratio will not come because of claims or anything. This combined ratio will come because operating leverage will be better. And I expect renewal cost operating leverage will be the only game changer in this."
Religare Broking: Q4 Rebound, Full-Year Reset
- Q4 showed what the business can do: PBT grew 79% YoY to INR12.9 crores, brokerage grew 41%, interest income grew 44%, and the e-governance business grew 31% YoY. The client debit book expanded 75% YoY.
- But the full year tells a repair story: Full-year top line declined 2% to INR373 crores and profit fell 26%, weighed down by a one-time charge related to new labour codes and a weak first three quarters.
- Client activity is the core problem to fix: NSE active clients fell 2% to 245,000 and unique traded clients dropped 5% to 140,000. The business has roughly 1 crore registered clients but only 2.5 lakh are active, leaving a large dormant base to reactivate. Industry-wide, the activity ratio has been falling from 40% in 2022.
- The repair playbook is process-led, not just product-led: Management has hired a Six Sigma/Lean expert and is focused on reactivating dormant accounts, improving technology including AI initiatives, and growing non-broking revenue through interest income and third-party distribution of investment and insurance products.
RFL: Clean, Debt-Free, and Waiting to Launch
- Legacy issues are conclusively resolved: Full-year PAT was INR139 crores driven by improved collections and recoveries, with Q4 PAT of INR89 crores. Collection efficiency is stable at around 98%, NNPA is approximately 0.8%, and CRAR stands at 261%. The balance sheet is entirely debt-free with no cumulative ALM mismatches.
- Q4 income nearly doubled YoY: Total income reached INR42.6 crores versus INR22 crores a year ago, driven by a sharp uptick in interest income to INR40.6 crores from INR18.2 crores. Pre-provision operating profit rose to INR17.6 crores from INR2 crores.
- The platform is ready, but the multi-line NBFC products are not yet launched: Management aims to create a multi-line NBFC with a mix of secured and unsecured products, distributed through a combination of branches and digital channels. Products will be launched over the next couple of quarters as technology platforms are readied. Once the stack is in place, scale-up is expected to be rapid and pan-India.
- New CEO joined literally this week: Karthik Srinivasan, formerly of HDB Financial Services, has taken charge as CEO of RFL, marking the final piece of the leadership rebuild across the group.
Pratul Gupta: "The cash is available. Capital is in place, people are there. Platform is now ready to do the business for the various business lines."
Religare Housing Finance: The Loss-Maker with a 12-18 Month Clock
- Small book, persistent losses: AUM stands at INR243 crores with a product mix of 70% home loans and 30% loan against property, at an average ticket size of INR10-11 lakhs. The full-year loss was INR18.6 crores, wider than the INR12.8 crore loss the previous year, though the quarterly loss narrowed to INR3.6 crores from INR5.9 crores in Q3.
- Revenue is flat but cost discipline is improving: Total revenue edged up to INR7.9 crores from INR7.1 crores, while operating expenses were trimmed to INR11.5 crores from INR13 crores.
- Current disbursements are negligible: The business is doing less than INR10 crores a month in disbursements. Management plans to start putting infrastructure and expansion blocks in place only after the first round of capital arrives.
- Profitability is 12 to 18 months away: Management was explicit that the HFC is the only group entity not reporting a profit and that scaling up will require both opex and capex, making a turnaround a medium-term proposition.
- Distribution is a Tier 2/3 city branch-led play: The focus will remain on affordable housing with ticket sizes below INR15 lakhs, distributed largely through a branch network in smaller cities.
Leadership, Governance & Capital Allocation
- The Board and C-suite have been substantially rebuilt: REL's Board was reconstituted with independent directors and promoter nominee directors post-RBI approval in July 2025. New CEOs have been appointed at Care Health (Ajay Kumar Shah), RFL (Karthik Srinivasan), and Religare Broking (Vijay Kumar Goel). A CFO and Executive Director has been placed at the HFC. The CEO search for the HFC is still in process, and CTOs are being hired for each company.
- Anuj Gulati's 15-year term at Care has ended per IRDA norms: He cannot serve at Care for a period of 2 to 3 years under IRDA guidelines, making the leadership transition at the insurance entity a regulatory necessity, not a choice.
- Promoters have put INR750 crores into the preferential rights issue: The Burman Group subscribed to 50% of the issue and also increased its stake through open market purchases to around 30.3%. Outstanding warrants, upon conversion, will lift the stake further.
- Capital allocation from the INR1,500 crore raise is earmarked: INR600 crores to Care Health, INR250 crores to housing finance, INR200 crores to the broking entity, and approximately INR375 crores for general corporate purposes.
- No strategic investor is planned: Kedaara remains a long-term partner, and management stated there is no plan to bring in a new strategic investor.
Arjun Lamba: "We are building a foundation on which we hope to build a profitable, scalable and sustainable business and remain committed to the same."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Care Health combined ratio | Approach 100% driven by operating leverage, not claims improvement | Within 2 years |
| Housing finance profitability | Turn around from current loss-making position | 12 to 18 months |
| NBFC product launch | Multi-line products (secured/unsecured mix) launched after technology platform readiness | Over the next couple of quarters |
| Care Health growth rate | Grow faster than the industry; range of 18% to 24% cited under analyst pushback | Sustained (no end date) |
| Demerger scheme implementation | REL shareholders receive 1 RFL share per REL share held; scheme approved by both boards | Subject to regulatory approvals (no date given) |
| Promoter stake increase toward IRDA threshold | Evaluate options to meet the 26% requirement at the insurance entity level | At an appropriate time (no date given) |
Key Metrics
| Metric | Q4 FY26 |
|---|---|
| Total income (REL consolidated) | ₹2,473 cr |
| Total income (REL consolidated, full year FY26) | ₹8,493 cr, vs ₹7,405 cr in FY25 |
| PAT (REL consolidated, full year FY26) | ₹73.16 cr |
| PBT (REL consolidated, full year FY26) | ₹87 cr, vs ₹243 cr in FY25 |
| Insurance segment revenue | ₹2,313 cr |
| Insurance segment PBT | ₹41 cr |
| Financial Services segment revenue | ~₹166 cr |
| Financial Services segment PBT | ₹127.5 cr |
| Care Health Insurance GWP | ₹3,511 cr (on 'n' basis), +29% YoY |
| Care Health Insurance PBT | ₹275 cr (on 'n' basis); ₹107 cr on 1/n basis |
| Care Health Insurance GWP (full year FY26) | ₹11,417 cr, +24% YoY |
| Care Health Insurance PBT (full year FY26) | ₹539 cr (on 'n' basis), +38% YoY; ₹519 cr under Ind AS |
| Care Health Insurance combined ratio (Ind AS) | 101.4%, improved 120 bps YoY |
| Care Health Insurance retail health market share | 11.6% of overall industry, 19.7% within SAHI |
| Care Health Insurance solvency ratio | 1.68, or 1.70 excluding mark-to-market impact on equity |
| Care Health Insurance claim settlement ratio | 97% |
| Care Health Insurance AUM | ₹10,944 cr |
| Care Health Insurance agents | ~4.11 lakh, with ~50,000 added during FY26 |
| Religare Broking total income | ₹98 cr, +18% YoY |
| Religare Broking PBT | ₹12.9 cr, +79% YoY |
| Religare Broking PAT | ₹11 cr |
| Religare Broking active clients (NSE) | 245,000, down 2% YoY |
| Religare Broking daily derivative turnover | +61% YoY |
| Religare Finvest (RFL) total income | ₹42.6 cr, vs ₹22 cr in Q4 FY25 |
| Religare Finvest (RFL) PAT | ₹89 cr |
| Religare Finvest (RFL) NNPA | ~0.8% |
| Religare Finvest (RFL) CRAR | 261% |
| Religare Finvest (RFL) tangible net worth | ~₹900 cr |
| Religare Housing Finance total income | ₹7.9 cr, vs ₹7.1 cr in Q3 FY26 |
| Religare Housing Finance loss | ₹3.6 cr, vs loss of ₹5.9 cr in Q3 FY26 |
| Religare Housing Finance AUM | ₹243 cr |
| Religare Housing Finance GNPA | 3.5% |
| Religare Housing Finance NNPA | 2.5% |
| Promoter stake in REL | ~30.3%, up ~4 ppt in Q4; expected to rise to ~34% post warrant conversion |